Skip to content
OpenCapital
Get started

Indivior Pharmaceuticals, Inc. INDV Change in Inventories

Change in Inventories at other companies

Alkermes logo
AlkermesALKS
$6.43M+267%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's change in inventories?
Indivior Pharmaceuticals, Inc. (INDV) reported change in inventories of $1M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's change in inventories changed year-over-year?
Indivior Pharmaceuticals, Inc. 's change in inventories increased by 120.0% year-over-year, from -$5M to $1M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's change in inventories?
Over 2 years (2022 to 2024), Indivior Pharmaceuticals, Inc. 's change in inventories has grown at a 19.7% compound annual growth rate (CAGR), from $30M to $43M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.